Department of Mechanical Engineering, Massachusetts Institute of Technology, 77 Massachusetts Ave, Cambridge, MA 02139, USA.
Institute for Medical Engineering and Science, Massachusetts Institute of Technology, 77 Massachusetts Ave, Cambridge, MA 02139, USA.
Sci Transl Med. 2021 Feb 17;13(581). doi: 10.1126/scitranslmed.abb3652.
A reported 96,480 people were diagnosed with melanoma in the United States in 2019, leading to 7230 reported deaths. Early-stage identification of suspicious pigmented lesions (SPLs) in primary care settings can lead to improved melanoma prognosis and a possible 20-fold reduction in treatment cost. Despite this clinical and economic value, efficient tools for SPL detection are mostly absent. To bridge this gap, we developed an SPL analysis system for wide-field images using deep convolutional neural networks (DCNNs) and applied it to a 38,283 dermatological dataset collected from 133 patients and publicly available images. These images were obtained from a variety of consumer-grade cameras (15,244 nondermoscopy) and classified by three board-certified dermatologists. Our system achieved more than 90.3% sensitivity (95% confidence interval, 90 to 90.6) and 89.9% specificity (89.6 to 90.2%) in distinguishing SPLs from nonsuspicious lesions, skin, and complex backgrounds, avoiding the need for cumbersome individual lesion imaging. We also present a new method to extract intrapatient lesion saliency (ugly duckling criteria) on the basis of DCNN features from detected lesions. This saliency ranking was validated against three board-certified dermatologists using a set of 135 individual wide-field images from 68 dermatological patients not included in the DCNN training set, exhibiting 82.96% (67.88 to 88.26%) agreement with at least one of the top three lesions in the dermatological consensus ranking. This method could allow for rapid and accurate assessments of pigmented lesion suspiciousness within a primary care visit and could enable improved patient triaging, utilization of resources, and earlier treatment of melanoma.
据报道,2019 年美国有 96480 人被诊断患有黑色素瘤,导致 7230 人报告死亡。在初级保健环境中早期识别可疑色素性病变(SPL)可以改善黑色素瘤的预后,并可能将治疗成本降低 20 倍。尽管具有这种临床和经济价值,但用于 SPL 检测的有效工具大多仍不存在。为了弥补这一差距,我们使用深度卷积神经网络(DCNN)开发了一种用于广域图像的 SPL 分析系统,并将其应用于从 133 名患者和公开可用图像中收集的 38283 个皮肤科数据集。这些图像是从各种消费级相机(15244 个非皮肤镜)获得的,并由三名董事会认证的皮肤科医生进行分类。我们的系统在区分 SPL 与非可疑病变、皮肤和复杂背景方面的灵敏度超过 90.3%(95%置信区间,90 至 90.6),特异性为 89.9%(89.6 至 90.2%),避免了繁琐的单个病变成像。我们还提出了一种新方法,基于从检测到的病变中提取的 DCNN 特征,提取患者内病变的显着性(丑小鸭标准)。在一组来自 68 名皮肤科患者的 135 张个别宽场图像上,使用未包含在 DCNN 训练集中的 3 名董事会认证的皮肤科医生对这种显着性排名进行了验证,该排名与皮肤科共识排名中至少前三个病变之一的至少 82.96%(67.88 至 88.26%)的一致性。这种方法可以在初级保健就诊期间快速准确地评估色素性病变的可疑性,并可以实现更好的患者分诊、资源利用和更早的黑色素瘤治疗。